Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tatjana Talamantes"'
Autor:
Lokesh Dalasanur Nagaprashantha, Tatjana Talamantes, Jyotsana Singhal, Jia Guo, Rit Vatsyayan, Navin Rauniyar, Sanjay Awasthi, Sharad S Singhal, Laszlo Prokai
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e71654 (2013)
The loss of von Hippel-Lindau (VHL) protein function leads to highly vascular renal tumors characterized by an aggressive course of disease and refractoriness to chemotherapy and radiotherapy. Loss of VHL in renal tumors also differs from tumors of o
Externí odkaz:
https://doaj.org/article/4d5afcdb06f246ecbddd2af1b80079d9
An Exploratory Evaluation of Tyrosine Hydroxylase Inhibition in Planaria as a Model for Parkinsonism
Autor:
Lewis R. Baxter, Tatjana Talamantes, Kurt Kamrowski, Laszlo Prokai, Thinh Nguyen, Ashwin Chandra, David Prokai
Publikováno v:
International Journal of Molecular Sciences, Vol 14, Iss 12, Pp 23289-23296 (2013)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Planaria are the simplest organisms with bilateral symmetry and a central nervous system (CNS) with cephalization; therefore, they could be useful as model organisms to investigate mechanistic aspects of parkinsonism and to screen potential therapeut
Publikováno v:
Proteomics. 14(9)
We present a proteomics dataset combining SDS-PAGE prefractionation and data-dependent LC-MS/MS that enables the identification of phosphatidylglycerol-regulated proteins in the pgsA(-) mutant of Synechocystis sp. PCC6803, a cyanobacterium strain tha
Autor:
Laszlo Prokai, Tatjana Talamantes, Sharad S. Singhal, Jyotsana Singhal, Lokesh Dalasanur Nagaprashantha, Navin Rauniyar, Rit Vatsyayan, Sanjay Awasthi, Jia Guo
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e71654 (2013)
PLoS ONE
PLoS ONE
Background The loss of von Hippel–Lindau (VHL) protein function leads to highly vascular renal tumors characterized by an aggressive course of disease and refractoriness to chemotherapy and radiotherapy. Loss of VHL in renal tumors also differs fro
Autor:
Sanjay Awasthi, Sharad S. Singhal, Laszlo Prokai, Tatjana Talamantes, Lokesh Dalasanur Nagaprashantha, Jyotsana Singhal
Publikováno v:
Journal of Clinical Oncology. 30:e13557-e13557
e13557 Background: Von Hippel-Lindau (VHL) tumor suppressor is a major genetic factor that determines hypoxic acclimatization and response to therapy in renal cell carcinoma (RCC). Our initial studies revealed that 2'-Hydroxyflavanone (2HF) effective